KRISHNA PANDEY: Open Payments
NPI 1669452223 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,002 in 46 payments from 19 companies in 2025. Trend: 2023 $1,083 · 2024 $994 · 2025 $1,002
Food & beverage: $1,002
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $247 |
| AstraZeneca Pharmaceuticals LP | 3 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
| UCB, Inc. | 3 | $67 |
| PFIZER INC. | 3 | $63 |
| Vanda Pharmaceuticals Inc. | 3 | $59 |
| Neurocrine BioSciences, Inc. | 2 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| Lundbeck LLC | 2 | $50 |
| Novo Nordisk Inc | 2 | $41 |
Products named: REXULTI, VRAYLAR, QULIPTA, Briviact, FANAPT, INGREZZA, LINZESS, ENTRESTO.
Industry payments across WI — which companies pay providers there.
